Mark Emmert, the former NCAA president, recently sold 4,100 shares of Expeditors International, a Bellevue, Wash.-based company where he has served on the board of directors since 2008. When he was appointed to the board, Emmert was president of the University of Washington, three years before he took over leadership of the NCAA.
According to recent SEC filings, Emmert sold the shares earlier this month for approximately $494,762. The transaction follows a previous stock sale in June 2024, when he unloaded a combined 5,636 shares for $1.01 million. Following the most recent sale, Emmert continues to hold 11,868 in Expeditors, worth roughly $1.43 million based on current market prices.
Expeditors recently announced that David Hackett, a longtime Nike executive, would be its new chief financial officer. A company spokesperson did not respond to an email seeking comment.
In addition to Expeditors, Emmert also sits on the board of Weyerhaeuser, the Seattle-based timberland company. As part of his compensation for that role—the equity portion of a $180,000 per year retainer fee—he has accumulated 58,449 shares of Weyerhaeuser, now valued around $1.5 million.
Emmert previously served on the board of Omnicare, the health insurance company, from 2011 to 2015, when it was acquired by CVS.
Emmert retired from the NCAA in June 2023; he received $6.34 million for the fiscal year 2024, which included $4.3 million in severance. Having once famously pledged that college athletes would never be paid, Emmert has since kept a low public profile. He and his wife retired to their 40-acre horse ranch in California’s wine country, which the couple purchased in 2018 for $5.65 million.
Emmert’s NCAA successor, current president Charlie Baker, serves on the board of UnitedHealthcare International, which has recently been rocked by controversy and tragedy. UnitedHealthcare CEO Brian Thompson was assassinated in a targeted attack, prompting a shareholders lawsuit alleging the company misled investors about the impact of his death.
As of last month, Baker had received 1,248 shares of UnitedHealth stock, worth around $377,000 midday Thursday. The company’s share price has declined nearly 50% from its one-year high.
